Showing results (1631-1640 of 3,401) with videos related to

Sort By:
Pageof 341
Neuromuscular Disorders : NMD|November 8, 2024
Acute weakness and elevated creatine kinase levels associated with coxsackievirus infection in LAMA2-related muscular dystrophyWui-Kwan Wong, Denise Warner, Richard Webster
Neuromuscular Disorders : NMD|November 10, 2024
Genotype and corticosteroid treatment are distinctively associated with gray matter characteristics in patients with Duchenne muscular dystrophySam Geuens, Jeroen Van Dessel, Hermien E Kan, et al.
Neuromuscular Disorders : NMD|August 9, 2024
Three novel missense variants in two families with JAG2-associated limb-girdle muscular dystrophyLein Dofash, Krishnan Lyengar, Nolette Pereira, et al.
Neuromuscular Disorders : NMD|August 14, 2024
Defining the landscape of TIA1 and SQSTM1 digenic myopathyPaula Panos-Basterra, Julian Theuriet, Aleksandra Nadaj-Pakleza, et al.
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Neuromuscular Disorders : NMD|June 12, 2024
Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophyMarianela Schiava, Robert Muni Lofra, John P Bourke, et al.
Neuromuscular Disorders : NMD|June 11, 2024
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3Danny R van der Woude, Renske I Wadman, Fay-Lynn Asselman, et al.
Neuromuscular Disorders : NMD|November 15, 2023
Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual realityJoana Garmendia, Garazi Labayru, Jone Aliri, et al.
Neuromuscular Disorders : NMD|November 17, 2023
Meeting report: The 2023 FSHD International Research CongressJamshid Arjomand, Davide Gabellini, Nicol Voermans, et al.
Pageof 341